The Latest Headlines at The Cerbat Gem
MSCI ACWI exAU/CONSUMER GRTR US (NASDAQ:RWAYL) Short Interest Up 58.2% in August
MSCI ACWI exAU/CONSUMER GRTR US (NASDAQ:RWAYL – Get Free Report) saw a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 4,787 shares, a growth of 58.2% from... More of this article »
MicroSectors U.S. Big Banks -3X Inverse Leveraged ETNs (NYSEARCA:BNKD) Sees Significant Growth in Short Interest
MicroSectors U.S. Big Banks -3X Inverse Leveraged ETNs (NYSEARCA:BNKD – Get Free Report) was the recipient of a large growth in short interest in the month of August. As of August 14th, there was short interest totaling 1,264... More of this article »
Arrowhead Pharmaceuticals’ (ARWR) “Buy” Rating Reiterated at Chardan Capital
Chardan Capital restated their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research report released on Monday,Benzinga reports. They currently have a $115.00 price target on the biotechnology... More of this article »
Honeywell International (NASDAQ:HON) Price Target Raised to $250.00
Honeywell International (NASDAQ:HON – Free Report) had its target price lifted by Morgan Stanley from $245.00 to $250.00 in a research report sent to investors on Monday morning,Benzinga reports. Morgan Stanley currently has... More of this article »
NVIDIA (NASDAQ:NVDA) Price Target Raised to $300.00
NVIDIA (NASDAQ:NVDA – Free Report) had its target price hoisted by Phillip Securities from $285.00 to $300.00 in a research note issued to investors on Monday morning, Marketbeat Ratings reports. Phillip Securities currently... More of this article »
Popular (NASDAQ:BPOP) Price Target Raised to $216.00
Popular (NASDAQ:BPOP – Free Report) had its price objective increased by Benchmark from $214.00 to $216.00 in a research note issued to investors on Monday morning, MarketBeat Ratings reports. They currently have a buy rating... More of this article »
Needham & Company LLC Cuts Maplight Therapeutics (NASDAQ:MPLT) Price Target to $43.00
Maplight Therapeutics (NASDAQ:MPLT – Free Report) had its target price trimmed by Needham & Company LLC from $45.00 to $43.00 in a research report sent to investors on Monday, MarketBeat Ratings reports. The brokerage currently... More of this article »
Omega Healthcare Investors (NYSE:OHI) Price Target Raised to $46.00
Omega Healthcare Investors (NYSE:OHI – Free Report) had its price target hoisted by Mizuho from $45.00 to $46.00 in a research note issued to investors on Monday morning, Marketbeat Ratings reports. Mizuho currently has a neutral... More of this article »
Akzo Nobel (OTCMKTS:AKZOF) Trading 2% Higher – What’s Next?
Akzo Nobel (OTCMKTS:AKZOF – Get Free Report)’s share price was up 2% on Wednesday . The stock traded as high as $68.85 and last traded at $68.8450. Approximately 3,651 shares changed hands during trading, an increase of... More of this article »
Sempra Energy’s (SRE) “Neutral” Rating Reiterated at Mizuho
Mizuho restated their neutral rating on shares of Sempra Energy (NYSE:SRE – Free Report) in a research report released on Monday, Marketbeat reports. They currently have a $84.00 price target on the utilities provider’s... More of this article »
Walmart’s (WMT) Buy Rating Reiterated at Tigress Financial
Tigress Financial reaffirmed their buy rating on shares of Walmart (NASDAQ:WMT – Free Report) in a research note released on Monday morning,Benzinga reports. Tigress Financial currently has a $155.00 price objective on the retailer’s... More of this article »
Bank of America Cuts Rocket Lab (NASDAQ:RKLB) Price Target to $110.00
Rocket Lab (NASDAQ:RKLB – Free Report) had its target price decreased by Bank of America from $115.00 to $110.00 in a research note published on Monday morning,Benzinga reports. Bank of America currently has a buy rating on the... More of this article »
Stifel Nicolaus Analysts Give Propel (TSE:PRL) a C$38.00 Price Target
Stifel Nicolaus set a C$38.00 price target on Propel (TSE:PRL – Free Report) in a report issued on Monday,BayStreet reports. The firm currently has a buy rating on the stock. A number of other equities analysts also recently... More of this article »